News and Announcements
Dr Mark’s Hygenie’s interview with CRIISP Media
- Published June 16, 2022 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Dr Mark’s HyGenie is a global consumer healthcare company in the oral hygiene space. The company offers an innovative range of easy-to-use oral hygiene products, purpose-designed to improve the world-wide standard of home and institutional care of Dentures, Sports Mouthguards and nearly all other types of Removable Dental Appliances.
Stephen Plakotaris, CEO and Managing Director of Dr Mark’s Hygenie, sat down with CRIISP Media Managing Editor Sidney Macdessi to talk about the company’s milestones and current market status.
The company has smartly utilised previous seed, start-up and grant capital raised (AU $3m) to develop its breakthrough care concept. It now distributes B2B, B2C and D2C in 12 countries. Reducing the physical, emotional and financial costs of dental appliance-related oral disease is the standout mission for Dr Mark’s Hygenie. To realise its mission, the company is now in a US $2m seed round to scale up the business for entry into the US market and drive mass adoption.
Watch the entire interview here: https://youtu.be/PVafFK5V5VI
Company Updates
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Beyond the Drip: Elemental IV’s Infrastructure Play for a Fragile Supply Chain
In the high-stakes world of life sciences, we often hunt for the next “miracle molecule” or gene-editing breakthrough. But Storme Paes, Founder and Commercial Director of Elemental IV, found her mission in something far more fundamental, yet dangerously overlooked: a simple bag of saltwater. The “Meeting Room” Revelation The genesis of Elemental IV didn’t occur […]
Backed By Leading Investment Groups and Family Offices
